Posted innews OB/GYN & Women's Health Specialties
FDA Advances Treatment for Hypoactive Sexual Desire Disorder in Postmenopausal Women
The FDA grants Priority Review to expand flibanserin use for treating low sexual desire in postmenopausal women, addressing an important gap in women's health.